These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2908522)

  • 1. Structural and functional properties of a 69-kilodalton outer membrane protein of Bordetella pertussis.
    Brennan MJ; Li ZM; Shahin RD; Burns DL; Nguyen NY; Liu TY; Gray MC; Hewlett EL; Manclark CR
    Tokai J Exp Clin Med; 1988; 13 Suppl():211-5. PubMed ID: 2908522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis.
    Brennan MJ; Li ZM; Cowell JL; Bisher ME; Steven AC; Novotny P; Manclark CR
    Infect Immun; 1988 Dec; 56(12):3189-95. PubMed ID: 2903126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor.
    Novotny P; Chubb AP; Cownley K; Montaraz JA; Beesley JE
    Dev Biol Stand; 1985; 61():27-41. PubMed ID: 2872113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel bivalent acellular pertussis vaccine based on the 69 kDa protein and FHA.
    Novotny P; Chubb AP; Cownley K; Charles IG
    Dev Biol Stand; 1991; 73():243-9. PubMed ID: 1778316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
    Cainelli Gebara VC; Risoléo L; Lopes AP; Ferreira VR; Quintilio W; Lépine F; Silva WD; Raw I
    Vaccine; 2007 Jan; 25(4):621-9. PubMed ID: 17011680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface antigens of Bordetella pertussis.
    Parker CD; Branes LV; Armstrong SK; Frank DW; Cole A
    Dev Biol Stand; 1985; 61():123-36. PubMed ID: 2872098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity of a human monoclonal antibody to Bordetella pertussis lipooligosaccharide.
    Brodeur BR; Hamel J; Martin D; Rondeau P
    Hum Antibodies Hybridomas; 1991 Oct; 2(4):194-9. PubMed ID: 1721552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and protective activities of outer membrane proteins from Bordetella.
    González-y-Merchand J; Ruiloba de León S; Estrada-García I; López-Flores C; Ortega-Ortega R; Ruíz-Puente J
    Rev Latinoam Microbiol; 1995; 37(1):33-41. PubMed ID: 7784730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.
    Zhang JM; Cowell JL; Steven AC; Manclark CR
    Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.
    Asensio CJ; Gaillard ME; Moreno G; Bottero D; Zurita E; Rumbo M; van der Ley P; van der Ark A; Hozbor D
    Vaccine; 2011 Feb; 29(8):1649-56. PubMed ID: 21211579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis.
    Shahin RD; Brennan MJ; Li ZM; Meade BD; Manclark CR
    J Exp Med; 1990 Jan; 171(1):63-73. PubMed ID: 2295882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model.
    Marr N; Oliver DC; Laurent V; Poolman J; Denoël P; Fernandez RC
    Vaccine; 2008 Aug; 26(34):4306-11. PubMed ID: 18582518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-cell immunity against Bordetella pertussis analyzed at clonal level.
    Tagliabue A; De Magistris MT; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():253-7. PubMed ID: 2908527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.
    Carbonetti NH; Artamonova GV; Andreasen C; Dudley E; Mays RM; Worthington ZE
    Infect Immun; 2004 Jun; 72(6):3350-8. PubMed ID: 15155640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
    Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME
    Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bordetella pertussis iron regulated proteins as potential vaccine components.
    Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
    Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane vesicles as acellular vaccine against pertussis.
    Roberts R; Moreno G; Bottero D; Gaillard ME; Fingermann M; Graieb A; Rumbo M; Hozbor D
    Vaccine; 2008 Aug; 26(36):4639-46. PubMed ID: 18640169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface antigens of Bordetella pertussis.
    Parker CD; Armstrong SK; Frank DW
    Adv Exp Med Biol; 1985; 185():117-27. PubMed ID: 2866677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
    David S; van Furth R; Mooi FR
    Vaccine; 2004 May; 22(15-16):1892-8. PubMed ID: 15121300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.